1 Min Read
Oct 4 (Reuters) - Newlink Genetics Corp
* Newlink Genetics awarded $25 million contract from BARDA for investigational Ebola Zaire vaccine (V920) Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.